Genetics Laboratories awarded UKAS flexible scope
We are pleased to announce that Viapath’s Genetics Laboratories have been granted a UKAS flexible scope for whole exome sequencing (WES) and preimplantation genetic diagnosis (PGD) testing. This will enable the laboratories to respond rapidly to new clinical requests and changes directed by NHS England for provision of genomics tests.
Flexible scope is granted when a laboratory successfully demonstrates a management system of sufficient quality to ‘self-validate’. This achievement allows Viapath to add further targets to the existing WES and PGD tests without having to apply to UKAS to for an extension to our scope.
Viapath is the first medical laboratory in the country that UKAS has been accredited to ISO 15189:2012 which includes a flexible scope for part of the whole accredited scope.
For further information, please contact
Jeremy Skinner: Jeremy [dot] Skinner [at] viapath [dot] co [dot] uk